DXCMNEUTRAL

Return on Equity (ROE)

35.6%

Updated 152h ago

Sector Performance

86th percentile

DXCM

35.6%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

A Return on Equity (ROE) of 35.6% means that for every dollar of shareholders' equity, DXCM generated $0.356 in profit over the trailing twelve months.

Compared to sector peers, this is well above the sector median of 13.7%, placing DXCM in the 85th percentile among those peers. The trend is not assessable because year-over-year change, quarter-over-quarter change, and the last eight quarters of data are all marked N/A. The combination of a high percentile rank with no trend information suggests that while current profitability is strong relative to peers, the lack of direction creates uncertainty around sustainability or improvement. This metric supports a NEUTRAL verdict because the elevated level alone does not justify an outright bullish stance without proven momentum, nor does it indicate deterioration.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about DXCM?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are DXCM's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

Advertisement

Master DXCM's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full DXCM research report

Free account — no credit card

DXCM

35.6%

Sector Median

13.8%

Sector Avg

31.4%

How DXCM's Return on Equity (ROE) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.